Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selective Retina Therapy (SRT) for Clinically Significant Diabetic Macular

NCT00994955 is registered in ClinicalTrials.gov with University Hospital Schleswig-Holstein as lead sponsor.

NCT NCT00994955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00994955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selective Retina Therapy (SRT) for Clinically Significant Diabetic Macular
Lead sponsor
University Hospital Schleswig-Holstein
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2006
Completion date
October 31, 2009
Enrollment
39 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema